JP2023513458A5 - - Google Patents
Info
- Publication number
- JP2023513458A5 JP2023513458A5 JP2022545126A JP2022545126A JP2023513458A5 JP 2023513458 A5 JP2023513458 A5 JP 2023513458A5 JP 2022545126 A JP2022545126 A JP 2022545126A JP 2022545126 A JP2022545126 A JP 2022545126A JP 2023513458 A5 JP2023513458 A5 JP 2023513458A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- cell
- car
- sequence
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062964947P | 2020-01-23 | 2020-01-23 | |
| US62/964,947 | 2020-01-23 | ||
| PCT/US2021/070073 WO2021151119A1 (en) | 2020-01-23 | 2021-01-23 | Chimeric antigen receptors to her2 and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513458A JP2023513458A (ja) | 2023-03-31 |
| JP2023513458A5 true JP2023513458A5 (https=) | 2024-01-31 |
| JP7737996B2 JP7737996B2 (ja) | 2025-09-11 |
Family
ID=76992754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545126A Active JP7737996B2 (ja) | 2020-01-23 | 2021-01-23 | Ｈｅｒ２に対するキメラ抗原受容体およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230072955A1 (https=) |
| EP (1) | EP4087867A4 (https=) |
| JP (1) | JP7737996B2 (https=) |
| KR (1) | KR20220153578A (https=) |
| CN (1) | CN115485293A (https=) |
| AU (1) | AU2021210446A1 (https=) |
| BR (1) | BR112022014568A2 (https=) |
| CA (1) | CA3168813A1 (https=) |
| IL (1) | IL294877A (https=) |
| MX (1) | MX2022009049A (https=) |
| WO (1) | WO2021151119A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250222029A1 (en) | 2022-04-08 | 2025-07-10 | Fate Therapeutics, Inc. | Chimeric antigen receptor for tumor targeting |
| US20250228943A1 (en) | 2022-04-08 | 2025-07-17 | Fate Therapeutics, Inc. | Cells having solid tumor targeting backbone and use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2289942B1 (en) * | 2002-04-10 | 2013-07-31 | Genentech, Inc. | Anti-HER2 antibody variants |
| MX2009010611A (es) * | 2007-04-03 | 2010-03-26 | Micromet Ag | Enlazadores biespecificos, especificos para especies. |
| US10208129B2 (en) * | 2010-12-06 | 2019-02-19 | National Research Council Of Canada | Antibodies selective for cells presenting ErbB2 at high density |
| CA2861003C (en) * | 2012-01-13 | 2023-03-28 | Julius-Maximilians-Universitat Wurzburg | Dual antigen-induced bipartite functional complementation |
| DK4074735T3 (da) * | 2014-08-28 | 2025-07-14 | Bioatla Inc | Betinget aktive kimæriske antigenreceptorer til modificerede t-celler |
| KR20180083874A (ko) * | 2015-11-04 | 2018-07-23 | 사울 제이. 프라이스맨 | Her2를 표적화하는 키메라 항원 수용체 |
| JP7280827B2 (ja) * | 2017-01-18 | 2023-05-24 | エクスマ バイオテック コーポレイション | Ａｘｌまたはｒｏｒ２に対するキメラ抗原受容体およびその使用方法 |
| US20190367876A1 (en) * | 2017-01-18 | 2019-12-05 | F1 Oncology, Inc. | Methods of transducing and expanding immune cells and uses thereof |
| AU2018261891B2 (en) * | 2017-05-05 | 2024-11-21 | Memorial Sloan Kettering Cancer Center | Modular self assembly disassembly (SADA) technologies |
| NZ762505A (en) * | 2017-09-29 | 2026-03-27 | Daiichi Sankyo Co Ltd | Antibody-pyrrolobenzodiazepine derivative conjugate |
| EP3735458A4 (en) * | 2018-01-03 | 2022-04-27 | Palleon Pharmaceuticals Inc. | RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS AND METHODS OF USE THEREOF |
| JP7527641B2 (ja) * | 2018-04-18 | 2024-08-05 | アブクロン・インコーポレイテッド | スイッチ分子及びスイッチャブルキメラ抗原受容体 |
-
2021
- 2021-01-23 US US17/759,242 patent/US20230072955A1/en active Pending
- 2021-01-23 MX MX2022009049A patent/MX2022009049A/es unknown
- 2021-01-23 EP EP21744303.5A patent/EP4087867A4/en active Pending
- 2021-01-23 BR BR112022014568A patent/BR112022014568A2/pt unknown
- 2021-01-23 CA CA3168813A patent/CA3168813A1/en active Pending
- 2021-01-23 KR KR1020227028048A patent/KR20220153578A/ko active Pending
- 2021-01-23 JP JP2022545126A patent/JP7737996B2/ja active Active
- 2021-01-23 IL IL294877A patent/IL294877A/en unknown
- 2021-01-23 WO PCT/US2021/070073 patent/WO2021151119A1/en not_active Ceased
- 2021-01-23 AU AU2021210446A patent/AU2021210446A1/en active Pending
- 2021-01-23 CN CN202180014430.7A patent/CN115485293A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0699237B1 (en) | Anti-egfr single-chain fvs and anti-egfr antibodies | |
| CN110229232B (zh) | 双特异性抗体及其用途 | |
| JP2018522564A (ja) | 抗グリピカン３抗体およびその使用 | |
| CN103833852A (zh) | 针对磷脂酰肌醇蛋白多糖-3和t细胞抗原的双特异性抗体 | |
| EP4317186A1 (en) | Nanobody targeting bcma and application thereof | |
| JP2023512452A (ja) | Ｂｃｍａ指向性細胞免疫療法組成物および方法 | |
| JP2022542559A5 (https=) | ||
| US20250051444A1 (en) | Multi-specific t cell engagers comprising lrrc15 antigen-binding domain | |
| WO2021219127A1 (zh) | 一种靶向her2和pd-1的双特异性抗体及其应用 | |
| CN116568709A (zh) | 靶向cd5的全人源抗体、全人源嵌合抗原受体（car）及其应用 | |
| JP2024516308A5 (https=) | ||
| CN112048019A (zh) | 抗人cd47单克隆抗体 | |
| TWI906795B (zh) | 特異性結合Ｃｌａｕｄｉｎ １８.２的抗體及其製法和應用 | |
| WO2025190367A1 (zh) | 抗cldn18.2的纳米抗体、嵌合抗原受体及其应用 | |
| CN109929037B (zh) | 针对程序性死亡配体的结合物及其应用 | |
| JP2023513458A5 (https=) | ||
| JP2022513321A5 (https=) | ||
| JP2022513321A (ja) | 固形腫瘍を治療するための遺伝子操作しているγδ－Ｔ細胞及び遺伝子操作していないγδ－Ｔ細胞に関する組成物及び方法 | |
| CN116410315A (zh) | 一种新型靶向人flt3的嵌合抗原受体修饰的t细胞的构建及应用 | |
| CN113825772A (zh) | 抗her2亲合体及将其用作开关分子的可切换嵌合抗原受体 | |
| CN114805581B (zh) | 靶向il13ra2的抗体、嵌合抗原受体及其用途 | |
| CN118754989B (zh) | 一种抗her2纳米抗体及其制备方法和应用 | |
| WO2024193669A1 (zh) | 抗tnfr2/抗pd-1或ctla-4双特异性抗体及其应用 | |
| CN110396131A (zh) | 一种ErbB2单链抗体、靶向人ErbB2的嵌合抗原受体、重组载体、重组细胞和应用 | |
| CN113354737B (zh) | 一种磷脂酰肌醇蛋白聚糖3抗体及其应用 |